4-boronophenylalanine has been researched along with Cancer of Mouth in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (50.00) | 29.6817 |
2010's | 7 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iwagami, T; Iwai, S; Kato, I; Masunaga, S; Nakazawa, M; Ono, K; Sakurai, Y; Yamatomo, N; Yura, Y | 1 |
Bauer, W; Garabalino, MA; Heber, EM; Molinari, AJ; Monti Hughes, A; Nigg, DW; Pozzi, EC; Schwint, AE; Trivillin, VA | 1 |
Aromando, RF; Blaumann, H; Calzetta, O; Heber, EM; Itoiz, ME; Longhino, J; Monti Hughes, A; Nievas, SI; Nigg, DW; Pozzi, E; Schwint, AE; Trivillin, VA | 1 |
Ariyoshi, Y; Kawabata, S; Kimura, Y; Maruhashi, A; Miyatake, S; Ono, K; Shimahara, M; Suzuki, M | 1 |
Arnopolskaya, AM; Khokhlov, VF; Kozlovskaya, NG; Kulakov, VN; Mitin, VN; Portnov, AA; Sheino, IN; Zaitsev, KN | 1 |
Aromando, RF; Heber, EM; Itoiz, ME; Pozzi, E; Schwint, AE; Trivillin, VA | 1 |
Fujita, Y; Iwai, S; Kato, I; Ohnishi, K; Ohnishi, T; Ono, K; Sakurai, Y; Yamamoto, N; Yura, Y | 1 |
Aromando, RF; Garabalino, MA; Heber, EM; Itoiz, ME; Miller, M; Molinari, AJ; Monti Hughes, A; Nigg, DW; Pozzi, EC; Schwint, AE; Thorp, S; Trivillin, VA | 1 |
Aromando, RF; Garabalino, MA; Heber, EM; Itoiz, ME; Miller, M; Molinari, AJ; Monti Hughes, A; Nigg, DW; Pozzi, EC; Schwint, AE; Thorp, SI; Trivillin, VA | 1 |
Chang, CW; Chou, FI; Hsiao, MC; Hwang, JJ; Lin, YC; Wang, SJ; Yang, BH | 1 |
Kato, I; Masunaga, S; Nagata, K; Obayashi, S; Ono, K; Sakurai, Y; Suzuki, M; Yura, Y | 1 |
Fujita, Y; Iwai, S; Kamida, A; Kato, I; Ono, K; Sakurai, Y; Suzuki, M; Yura, Y | 1 |
Blaumann, H; Calzetta, O; Itoiz, ME; Kreimann, EL; Longhino, J; Schwint, AE | 1 |
Batistoni, D; Dagrosa, A; FarÃas, S; Garavaglia, R; Itoiz, ME; Kreimann, EL; Schwint, AE | 1 |
14 other study(ies) available for 4-boronophenylalanine and Cancer of Mouth
Article | Year |
---|---|
Sonoporation as an enhancing method for boron neutron capture therapy for squamous cell carcinomas.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Membrane; Female; Humans; Isotopes; Mice; Mice, Inbred BALB C; Mice, Nude; Microbubbles; Mouth Neoplasms; Neoplasm Transplantation; Neutrons; Phenylalanine; Radiotherapy; Ultrasonics | 2013 |
Boron biodistribution for BNCT in the hamster cheek pouch oral cancer model: combined administration of BSH and BPA.
Topics: Animals; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Cheek; Cricetinae; Drug Combinations; Mesocricetus; Metabolic Clearance Rate; Mouth Neoplasms; Organ Specificity; Phenylalanine; Radiotherapy Dosage; Sulfhydryl Compounds; Tissue Distribution; Treatment Outcome | 2014 |
Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Cricetinae; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Phenylalanine; Precancerous Conditions; Radiation-Sensitizing Agents; Sulfhydryl Compounds; Tissue Distribution | 2009 |
Boron neutron capture therapy for recurrent oral cancer and metastasis of cervical lymph node.
Topics: Adult; Aged; Aged, 80 and over; Boron Compounds; Boron Neutron Capture Therapy; Female; Fluorine Radioisotopes; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck; Neoplasm Recurrence, Local; Pain; Phenylalanine; Positron-Emission Tomography; Quality of Life; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Comparison of BNCT and GdNCT efficacy in treatment of canine cancer.
Topics: Animals; Bone Neoplasms; Boron Compounds; Boron Neutron Capture Therapy; Combined Modality Therapy; Dog Diseases; Dogs; Gadolinium; Humans; Melanoma; Mouth Neoplasms; Neoplasms; Neutron Capture Therapy; Osteosarcoma; Phenylalanine | 2009 |
Early effect of boron neutron capture therapy mediated by boronophenylalanine (BPA-BNCT) on mast cells in premalignant tissue and tumors of the hamster cheek pouch.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cell Count; Cell Line, Tumor; Cell Proliferation; Cheek; Cricetinae; Mast Cells; Mouth Neoplasms; Phenylalanine; Precancerous Conditions; Radiation-Sensitizing Agents | 2010 |
Induction of multinucleation in oral squamous cell carcinoma tissue with mutated p53 surviving boron neutron capture therapy.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Female; Genes, p53; Mice; Mice, Inbred BALB C; Mice, Nude; Mitosis; Mouth Neoplasms; Mutation; Neoplasm Transplantation; Phenotype; Phenylalanine; Radiation-Sensitizing Agents | 2011 |
Boron Neutron Capture Therapy (BNCT) in an oral precancer model: therapeutic benefits and potential toxicity of a double application of BNCT with a six-week interval.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cheek; Cricetinae; Disease Models, Animal; DNA; Mouth Neoplasms; Mucositis; Phenylalanine; Precancerous Conditions; Radiation Injuries, Experimental; Treatment Outcome | 2011 |
Tumor blood vessel "normalization" improves the therapeutic efficacy of boron neutron capture therapy (BNCT) in experimental oral cancer.
Topics: Angiogenesis Inhibitors; Animals; Blood Vessels; Boron Compounds; Boron Neutron Capture Therapy; Cheek; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Radiation; Mouth Neoplasms; Phenylalanine; Thalidomide; Treatment Outcome | 2012 |
Macro- and microdistributions of boron drug for boron neutron capture therapy in an animal model.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cell Line, Tumor; Fluorine Radioisotopes; Fructose; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; Phenylalanine; Positron-Emission Tomography; Xenograft Model Antitumor Assays | 2012 |
Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Topics: Animals; Borohydrides; Boron; Boron Compounds; Boron Neutron Capture Therapy; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Female; Isotopes; Mice; Mice, Nude; Mouth Neoplasms; Phenylalanine; Relative Biological Effectiveness; Sulfhydryl Compounds | 2004 |
Effect of neutron capture therapy on the cell cycle of human squamous cell carcinoma cells.
Topics: Boron Compounds; Boron Neutron Capture Therapy; Carcinoma, Squamous Cell; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Humans; Mouth Neoplasms; Phenylalanine; Tumor Suppressor Protein p53 | 2008 |
Boron neutron capture therapy for the treatment of oral cancer in the hamster cheek pouch model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Boron Compounds; Boron Neutron Capture Therapy; Carcinogens; Cheek; Cricetinae; Disease Models, Animal; Mesocricetus; Mouth Neoplasms; Phenylalanine; Precancerous Conditions; Radiation-Sensitizing Agents | 2001 |
The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Boron; Boron Compounds; Boron Neutron Capture Therapy; Carcinogens; Cheek; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Mesocricetus; Mouth Neoplasms; Phenylalanine; Radiation-Sensitizing Agents; Tissue Distribution | 2001 |